Condition

Bladder Cancer (1)

Colorectal Cancer (1)

Head and Neck Cancer (1)

Melanoma (1)

Non-Small Cell Lung Cancer (1)

Other Solid Cancers (1)

Renal Cancer (1)

Triple Negative Breast Cancer (1)

Overall Status

Active, not recruiting (1)

Sign in for free

Phase

phase 1 (1)

Sponsor

Genentech, Inc. (1)

Collaborator

BioNTech SE (1)

Intervention

atezolizumab (1)

autogene cevumeran (1)

Study Documents

Intervention Type

drug (1)

Funder Type

Industry (1)

Study Type

Interventional (1)

other solid cancers

Showing 1 - 1 of 1

Trials per page:

STUDY

CONDITIONS

INTERVENTIONS

LOCATIONS

Melanoma, NSCLC, Bladder Cancer Trial in Worldwide (Autogene cevumeran, Atezolizumab)

Active, not recruiting

Melanoma
+7 more

Autogene cevumeran
Atezolizumab

Scottsdale, Arizona
+36 more

Dec 22, 2022